VoxCell BioInnovation is advancing the future of in vitro modeling.
We develop 3D bioprinted, vascularized human-like tissue models that closely replicate native biology, offering a powerful tool for more predictive, physiologically relevant research. Leveraging our proprietary high-resolution bioprinter, advanced vascularization software, and Universal Bioinks™, we produce complex tissue models that mirror patient biopsy samples in structure and function.
Our flagship product is a 3D vascularized model of Triple Negative Breast Cancer (TNBC), designed to support applications in disease modeling, drug screening, vascular toxicity, and targeted delivery.
Delivered as ready-to-use, perfusable models, VoxCell’s consumable products serve pharmaceutical companies, biotech firms, CROs, and academic researchers seeking to reduce translational gaps and accelerate biomedical innovation.
Company Details
- Employees
- 33
- Founded
- -
- Address
- Victoria, Bc, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.voxcellbio.com/
- Keywords
- Bioprinting, Tissue Engineering, Biotechnology, 3D Bioprinting, Drug Development, Vascularization, Cancer, Personalized Medicine, Oncology, Pre-clinical, Tissue Models, In Vitro.
- HQ
- Victoria, BC
Voxcell Bioinnovation Questions
Voxcell Bioinnovation's website is https://www.voxcellbio.com/
Voxcell Bioinnovation's LinkedIn profile is https://ca.linkedin.com/company/voxcellbio
Voxcell Bioinnovation has
33 employees.
View email and phone details for 33
employees at Voxcell Bioinnovation.
Voxcell Bioinnovation's industry is
Biotechnology Research
Voxcell Bioinnovation's top competitors are
Kumulus Water,
Axolotl Biosciences,
Exobiosphere,
Aspect Biosystems,
Daleela By Motherbeing,
Ivvest,
Nanopalm | نانو بالم,
Compup (Yc S22),
Lisan,
Brelyon.
Voxcell Bioinnovation's categories are Biotechnology Research
Voxcell Bioinnovation's founding year is 2020
